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Abstract
This editorial article summarizes last year’s achievements
and current plans for 2015 that focuses on attracting a high
quality, variety of articles with more emphasis in engaging
with academia and industry in the field of nanotechnology
and biomedical research.
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During the past year, we are proud to announce several
developments, first is our world class Associate Editors and
Editorial Board members that are key opinion leaders in
their respective expertise in the field of nanobiomedicine.
We are currently continuing to expand our Editorial Board,
however we would like to expand the expertise in the
diagnostics, vaccine development/implementation and
regenerative medicine space, as the fields are very broad-
based.
NBM Editor-in-Chief and editorial board members were
active in several events that took place in Boston and in
Czech Republic. The two events in Boston included the
“Micro- and Nanotechnologies for Medicine: Emerging
Frontiers and Applications” (BioMEMS) workshop hosted
by the journal's Editorial Board Member, Dr. Ali Khadem‐
hosseini and the other was “Science Shaping Our World”,
held at the Merck Research Laboratories, where two of our
NBM Editorial Board Members, Omar A. Ali and Qimin
Quan presented. NBM’s Editor-in-Chief, Dr. Markus
Dettenhofer - CEITEC Executive Director, took an active
part in organizing the annual "Conference Brno 2014:
Frontiers in Material and Life Sciences", sponsored by his
institution, CEITEC (Central European Institute for
Technology).
Lastly, Barbara S. Smith, Ph.D. (Arizona State University,
USA), one of our Editorial Board members, is currently the
Guest Editor of an ongoing Special Issue which was
launched in October 2014, entitled “Nanobiomedicine -
Meeting the Needs of Health Care across the Globe”. This
special issue is devoted to publishing the latest significant
innovative results in the global health spectrum – through
solutions tuned for different regions throughout the world;
encouraging research that uses new methods of disease
diagnosis, including technological and product develop‐
ment for enhanced point-of-care and personalized health
care. The aim of this edition is to spur both excitement and
knowledge, in and out of the field, helping to open new
market opportunities towards shifting cost and use
paradigms. Submissions of scientific results that highlight
the current path – from the research bench to the hands of
the user – by technical experts within both academia and
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industry are welcome. (http://www.intechopen.com/
journals/invitation/snbm-nanobiomedicine-meeting-the-
needs-of-health-care-across-the-globe)
We are  quite  pleased with the  number  of  high quality
publications  since  the  launch of  NBM. The majority  of
papers  discuss  research around nanoparticles  and their
applications. We will reach out to other areas including,
but  not  limited  to  the  following  areas;  bioengineering,
biophysics,  biochemistry,  physiology,  pathology,  nano-
technological  applications  in  diagnostics,  therapeutic
application,  vaccine,  drug  discovery/delivery  and
regenerative medicine.
NBM accepts original and review articles as well as
editorials, perspectives, short research reports, protocols
and methods, letters to the editor and meeting dispatch
reports.
We would like to mention, Intech publishers have decided
that NBM will not apply any article processing charges for
authors whose research papers have been accepted for
publication in Volume 2/2015. The NBM manuscript
processing and peer-review is conducted entirely online.
The Editorial Manager facilitates the manuscript process‐
ing time, reducing costs and is a better experience for our
authors and reviewers. We have received numerous
positive comments on this evolving electronic system, and
we are indebted to Intech publishers for managing this
program for us. For more information, please visit our new
manuscript submission system at http://www.editorial‐
manager.com/nmnt/. In addition, we are enforcing to
expedite the acceptance to publishing time for our authors
and will request informal opinions from our Editorial
Board for borderline cases.
In addition, we are pleased to have established a partner‐
ship/collaboration with the BioPharma Research Council
(http://www.biopharmaresearchcouncil.org/), spearhead‐
ed by Joanne Gere, the Executive Director. The BioPharma
Research Council has been developing a vibrant commun‐
ity for scientists as they navigate today's complex environ‐
ments. Our unique resources - including deep relationships
with leading companies and suppliers - and agile ap‐
proaches have established continual opportunities for
breakthrough discussion and debate throughout the drug
discovery and delivery pipeline. We plan to launch 2
webinar series, one on point of care diagnostics and the
other in drug delivery later this year and are currently
looking for presenters. A meeting dispatch will be publish‐
ed in NBM after each series.
NBM will continue to work on partnering with other
scientific societies, academic and industry leaders to
develop and advance the nanotechnology and biomedical
research field and to allow free access to the readers.
We finally would like to thank InTech publisher for
supporting the initiatives of this journal and acknowledge
Petra Nenadic and her team for her continuous support,
passion and dedication for making this possible. In
addition, we would like to thank our highly renowned and
respected Associate Editors and Editorial Board members
from all over the world, whose expertise range from nano-
fluidic systems to nano-scale drug delivery to nano-
imaging that are bridge and a catalyst in their respective
fields of nanotechnology and biomedical research.
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